Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |